| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | T cell receptor binding | 5.58e-08 | 20 | 106 | 5 | GO:0042608 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 9.26e-08 | 9 | 106 | 4 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 9.26e-08 | 9 | 106 | 4 | GO:0062061 | |
| GeneOntologyMolecularFunction | TAP1 binding | 1.54e-07 | 10 | 106 | 4 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 1.54e-07 | 10 | 106 | 4 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 1.54e-07 | 10 | 106 | 4 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 3.59e-07 | 12 | 106 | 4 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.69e-06 | 17 | 106 | 4 | GO:0046703 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 2.32e-06 | 161 | 106 | 8 | GO:0051087 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 6.07e-06 | 49 | 106 | 5 | GO:0042605 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 2.41e-05 | 32 | 106 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HSPD1 PRUNE2 AGAP5 SLC25A42 BRIP1 AGAP11 ACYP2 DHX15 ARHGAP5 DCP1B NAV2 RASEF AGAP9 AGAP4 AGAP6 | 3.63e-05 | 839 | 106 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HSPD1 PRUNE2 AGAP5 SLC25A42 BRIP1 AGAP11 ACYP2 DHX15 ARHGAP5 DCP1B NAV2 RASEF AGAP9 AGAP4 AGAP6 | 3.68e-05 | 840 | 106 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HSPD1 PRUNE2 AGAP5 SLC25A42 BRIP1 AGAP11 ACYP2 DHX15 ARHGAP5 DCP1B NAV2 RASEF AGAP9 AGAP4 AGAP6 | 3.68e-05 | 840 | 106 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | antigen binding | 6.97e-05 | 190 | 106 | 7 | GO:0003823 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 7.19e-05 | 42 | 106 | 4 | GO:0071889 | |
| GeneOntologyMolecularFunction | MHC protein binding | 2.55e-04 | 58 | 106 | 4 | GO:0042287 | |
| GeneOntologyMolecularFunction | BH3 domain binding | 4.13e-04 | 6 | 106 | 2 | GO:0051434 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RAF1 AGAP5 CDC20B AGAP11 ARHGAP5 GPIHBP1 RACK1 DCP1B AGAP9 AGAP4 AGAP6 | 7.28e-04 | 656 | 106 | 11 | GO:0008047 |
| GeneOntologyMolecularFunction | death domain binding | 1.49e-03 | 11 | 106 | 2 | GO:0070513 | |
| GeneOntologyMolecularFunction | peptide binding | 1.54e-03 | 318 | 106 | 7 | GO:0042277 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 2.10e-03 | 13 | 106 | 2 | GO:0008046 | |
| GeneOntologyMolecularFunction | GTPase activity | 2.29e-03 | 341 | 106 | 7 | GO:0003924 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 2.36e-03 | 439 | 106 | 8 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 2.36e-03 | 439 | 106 | 8 | GO:0019001 | |
| GeneOntologyMolecularFunction | BH domain binding | 2.44e-03 | 14 | 106 | 2 | GO:0051400 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HSPD1 AGAP5 BRIP1 AGAP11 DHX15 ARHGAP5 NAV2 RASEF AGAP9 AGAP4 AGAP6 | 2.73e-03 | 775 | 106 | 11 | GO:0017111 |
| GeneOntologyMolecularFunction | high-density lipoprotein particle binding | 2.80e-03 | 15 | 106 | 2 | GO:0008035 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.30e-03 | 188 | 106 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 3.75e-03 | 279 | 106 | 6 | GO:0005096 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 2.61e-09 | 25 | 106 | 6 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 1.30e-08 | 32 | 106 | 6 | GO:0019883 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 4.54e-08 | 8 | 106 | 4 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.02e-07 | 23 | 106 | 5 | GO:0019885 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 3.01e-07 | 53 | 106 | 6 | GO:0001914 | |
| GeneOntologyBiologicalProcess | positive regulation of type II interferon production | 1.02e-06 | 103 | 106 | 7 | GO:0032729 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 1.14e-06 | 16 | 106 | 4 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 1.49e-06 | 17 | 106 | 4 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 1.49e-06 | 17 | 106 | 4 | GO:0002476 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 1.60e-06 | 70 | 106 | 6 | GO:0001913 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 1.70e-06 | 111 | 106 | 7 | GO:0002709 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 1.91e-06 | 18 | 106 | 4 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.91e-06 | 18 | 106 | 4 | GO:0042590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 2.11e-06 | 41 | 106 | 5 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 2.23e-06 | 74 | 106 | 6 | GO:0002711 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 2.38e-06 | 42 | 106 | 5 | GO:0001916 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 2.61e-06 | 76 | 106 | 6 | GO:0048002 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 3.28e-06 | 79 | 106 | 6 | GO:0001912 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 3.56e-06 | 124 | 106 | 7 | GO:0001910 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 4.68e-06 | 48 | 106 | 5 | GO:0002478 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 6.15e-06 | 88 | 106 | 6 | GO:0031343 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 7.67e-06 | 25 | 106 | 4 | GO:0002475 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 1.09e-05 | 147 | 106 | 7 | GO:0031341 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 1.20e-05 | 58 | 106 | 5 | GO:0019884 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 1.25e-05 | 150 | 106 | 7 | GO:0002708 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon production | 1.55e-05 | 155 | 106 | 7 | GO:0032649 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 2.11e-05 | 109 | 106 | 6 | GO:0090630 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.11e-05 | 65 | 106 | 5 | GO:0000288 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 2.14e-05 | 163 | 106 | 7 | GO:0002456 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 2.40e-05 | 33 | 106 | 4 | GO:0000289 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 2.66e-05 | 232 | 106 | 8 | GO:0002706 | |
| GeneOntologyBiologicalProcess | type II interferon production | 2.70e-05 | 169 | 106 | 7 | GO:0032609 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 3.38e-05 | 175 | 106 | 7 | GO:0002705 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 4.61e-05 | 14 | 106 | 3 | GO:0060213 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 5.15e-05 | 187 | 106 | 7 | GO:0001909 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 7.04e-05 | 16 | 106 | 3 | GO:0060211 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 8.25e-05 | 139 | 106 | 6 | GO:0019882 | |
| GeneOntologyBiologicalProcess | T cell mediated immune response to tumor cell | 8.51e-05 | 17 | 106 | 3 | GO:0002424 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | HSPD1 HLA-A HLA-C HLA-DRA HLA-G HLA-H RASGRP1 IGLC6 IGLL1 MUC4 | 1.07e-04 | 449 | 106 | 10 | GO:0002449 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | HSPD1 CADM3 ABL2 CARMIL2 HLA-A EMB HLA-DRA HLA-G MDGA2 RASGRP1 NEO1 HMCN2 ROBO2 SIGLEC1 MUC4 CD276 | 1.20e-04 | 1077 | 106 | 16 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.26e-04 | 150 | 106 | 6 | GO:0002824 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 1.27e-04 | 290 | 106 | 8 | GO:0050870 | |
| GeneOntologyBiologicalProcess | positive regulation of motor neuron apoptotic process | 1.56e-04 | 4 | 106 | 2 | GO:2000673 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 1.73e-04 | 159 | 106 | 6 | GO:0002821 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 1.96e-04 | 309 | 106 | 8 | GO:0002703 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.13e-04 | 235 | 106 | 7 | GO:0002822 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 2.33e-04 | 317 | 106 | 8 | GO:1903039 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | HSPD1 RAF1 AGAP5 ABL2 CDC20B BAX AGAP11 RASGRP1 GPIHBP1 RACK1 DCP1B AGAP9 AGAP4 AGAP6 MUSK | 2.42e-04 | 1028 | 106 | 15 | GO:0043085 |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | 2.48e-04 | 406 | 106 | 9 | GO:0032943 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | HSPD1 AGAP5 BAX AGAP11 RASGRP1 GPIHBP1 RACK1 AGAP9 AGAP4 AGAP6 | 2.51e-04 | 499 | 106 | 10 | GO:0051345 |
| GeneOntologyBiologicalProcess | positive regulation of catabolic process | CDC20B BAX TNRC6B TNRC6C SH3BP4 RACK1 DCP1B TBK1 ELAPOR1 TNRC6A LRP2 TNKS1BP1 | 2.57e-04 | 701 | 106 | 12 | GO:0009896 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | 2.68e-04 | 244 | 106 | 7 | GO:0043547 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 3.26e-04 | 252 | 106 | 7 | GO:0002819 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | 3.38e-04 | 335 | 106 | 8 | GO:0043087 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity directed against tumor cell target | 3.87e-04 | 6 | 106 | 2 | GO:0002419 | |
| GeneOntologyBiologicalProcess | neuron development | ABL2 HLA-A HLA-C EMB HLA-G HLA-H PCARE EPB41L3 PHGDH NEO1 HMCN2 CAPRIN2 KLK8 LRP2 ROBO2 PBX2 MUSK STRCP1 | 4.50e-04 | 1463 | 106 | 18 | GO:0048666 |
| GeneOntologyBiologicalProcess | leukocyte proliferation | 4.84e-04 | 445 | 106 | 9 | GO:0070661 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 5.34e-04 | 31 | 106 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | HSPD1 RAF1 COL7A1 AGAP5 BAX AGAP11 SH3BP4 RASGRP1 GPIHBP1 RACK1 AGAP9 AGAP4 AGAP6 | 5.65e-04 | 878 | 106 | 13 | GO:0051336 |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 6.01e-04 | 132 | 106 | 5 | GO:0000956 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 6.33e-04 | 462 | 106 | 9 | GO:0002460 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 7.12e-04 | 137 | 106 | 5 | GO:0033135 | |
| GeneOntologyBiologicalProcess | T cell proliferation | 7.22e-04 | 288 | 106 | 7 | GO:0042098 | |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | HSPD1 HLA-A HLA-C HLA-DRA HLA-G HLA-H RASGRP1 IGLC6 IGLL1 MUC4 | 7.70e-04 | 576 | 106 | 10 | GO:0002443 |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | HSPD1 ABL2 CARMIL2 HLA-A HLA-DRA HLA-G MDGA2 RASGRP1 MUC4 CD276 | 8.11e-04 | 580 | 106 | 10 | GO:0022407 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 8.42e-04 | 385 | 106 | 8 | GO:0051251 | |
| GeneOntologyBiologicalProcess | neuron projection development | ABL2 HLA-A HLA-C EMB HLA-G HLA-H EPB41L3 PHGDH NEO1 HMCN2 CAPRIN2 KLK8 LRP2 ROBO2 MUSK STRCP1 | 8.51e-04 | 1285 | 106 | 16 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 9.00e-04 | 389 | 106 | 8 | GO:0022409 | |
| GeneOntologyBiologicalProcess | protection from natural killer cell mediated cytotoxicity | 9.20e-04 | 9 | 106 | 2 | GO:0042270 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | HSPD1 RAF1 AGAP5 ABL2 CDC20B BAX AGAP11 RASGRP1 GPIHBP1 RACK1 DCP1B TMEM132A AGAP9 AGAP4 AGAP6 MUSK WNK3 | 9.68e-04 | 1430 | 106 | 17 | GO:0044093 |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | 1.04e-03 | 398 | 106 | 8 | GO:0046651 | |
| GeneOntologyBiologicalProcess | cell killing | 1.05e-03 | 307 | 106 | 7 | GO:0001906 | |
| GeneOntologyBiologicalProcess | positive regulation of immune effector process | 1.26e-03 | 317 | 106 | 7 | GO:0002699 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-2 production | 1.31e-03 | 42 | 106 | 3 | GO:0032743 | |
| GeneOntologyBiologicalProcess | regulation of immune response | HSPD1 CARMIL2 HLA-A HLA-C ERAP1 HLA-DRA HLA-G HLA-H BAX RASGRP1 TBK1 IGLC6 MUC4 CD276 | 1.31e-03 | 1085 | 106 | 14 | GO:0050776 |
| GeneOntologyBiologicalProcess | positive regulation of immune response | HSPD1 CARMIL2 HLA-A HLA-C HLA-DRA HLA-G HLA-H BAX RASGRP1 TBK1 IGLC6 CD276 | 1.33e-03 | 845 | 106 | 12 | GO:0050778 |
| GeneOntologyBiologicalProcess | negative regulation of T cell mediated cytotoxicity | 1.40e-03 | 11 | 106 | 2 | GO:0001915 | |
| GeneOntologyBiologicalProcess | vagina development | 1.40e-03 | 11 | 106 | 2 | GO:0060068 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 1.53e-03 | 423 | 106 | 8 | GO:0002696 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 2.00e-08 | 35 | 105 | 6 | GO:0098553 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 2.08e-08 | 7 | 105 | 4 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 1.23e-07 | 10 | 105 | 4 | GO:0042612 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.44e-07 | 48 | 105 | 6 | GO:0098576 | |
| GeneOntologyCellularComponent | MHC protein complex | 1.76e-07 | 26 | 105 | 5 | GO:0042611 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 5.79e-07 | 14 | 105 | 4 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 1.36e-06 | 17 | 105 | 4 | GO:0033106 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 4.94e-06 | 23 | 105 | 4 | GO:0005797 | |
| GeneOntologyCellularComponent | coated vesicle | HSPD1 COL7A1 VWF HLA-A HLA-C HLA-DRA HLA-G HLA-H SH3BP4 LRP2 | 1.37e-05 | 360 | 105 | 10 | GO:0030135 |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 1.75e-05 | 64 | 105 | 5 | GO:0012507 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 1.95e-05 | 110 | 105 | 6 | GO:0030134 | |
| GeneOntologyCellularComponent | cell surface | HSPD1 VWF HLA-A HLA-C HLA-DRA HLA-G HLA-H NEO1 GPIHBP1 LMO7 LRP2 ROBO2 OSMR MUSK IL17RB STRCP1 CD276 | 3.72e-05 | 1111 | 105 | 17 | GO:0009986 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 5.81e-05 | 42 | 105 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | external side of plasma membrane | VWF HLA-A HLA-C HLA-DRA HLA-G HLA-H GPIHBP1 LRP2 OSMR MUSK CD276 | 6.04e-05 | 519 | 105 | 11 | GO:0009897 |
| GeneOntologyCellularComponent | side of membrane | VWF CARMIL2 HLA-A HLA-C HLA-DRA HLA-G HLA-H MDGA2 GPIHBP1 ALG9 LRP2 OSMR MUSK CD276 | 1.22e-04 | 875 | 105 | 14 | GO:0098552 |
| GeneOntologyCellularComponent | Golgi cisterna | 6.01e-04 | 135 | 105 | 5 | GO:0031985 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 7.09e-04 | 212 | 105 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 7.62e-04 | 215 | 105 | 6 | GO:0030662 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 8.14e-04 | 83 | 105 | 4 | GO:0030670 | |
| GeneOntologyCellularComponent | cis-Golgi network | 8.91e-04 | 85 | 105 | 4 | GO:0005801 | |
| GeneOntologyCellularComponent | Golgi stack | 1.73e-03 | 171 | 105 | 5 | GO:0005795 | |
| GeneOntologyCellularComponent | P-body | 1.75e-03 | 102 | 105 | 4 | GO:0000932 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 1.78e-03 | 443 | 105 | 8 | GO:0098791 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 2.19e-03 | 14 | 105 | 2 | GO:0071735 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.46e-03 | 112 | 105 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 3.66e-03 | 125 | 105 | 4 | GO:0140534 | |
| MousePheno | spinal cord inflammation | 1.15e-07 | 8 | 91 | 4 | MP:0030987 | |
| MousePheno | fused cornea and lens | 4.03e-07 | 24 | 91 | 5 | MP:0001307 | |
| Domain | IG_LIKE | CADM3 HLA-A HLA-C EMB HLA-DRA HLA-G MYOM3 HLA-H MDGA2 IGSF22 NEO1 HMCN2 ROBO2 SIGLEC1 IGLL1 MUSK CD276 | 1.49e-09 | 491 | 103 | 17 | PS50835 |
| Domain | Ig-like_dom | CADM3 HLA-A HLA-C EMB HLA-DRA HLA-G MYOM3 HLA-H MDGA2 IGSF22 NEO1 HMCN2 ROBO2 SIGLEC1 IGLL1 MUSK CD276 | 2.14e-09 | 503 | 103 | 17 | IPR007110 |
| Domain | Ig-like_fold | CADM3 COL7A1 HLA-A HLA-C EMB HLA-DRA HLA-G MYOM3 HLA-H MDGA2 IGSF22 NEO1 HMCN2 ROBO2 SIGLEC1 IGLL1 OSMR MUSK CD276 | 9.21e-09 | 706 | 103 | 19 | IPR013783 |
| Domain | IGc1 | 2.35e-08 | 56 | 103 | 7 | SM00407 | |
| Domain | Ig_C1-set | 3.01e-08 | 58 | 103 | 7 | IPR003597 | |
| Domain | Ig_I-set | 9.74e-08 | 190 | 103 | 10 | IPR013098 | |
| Domain | I-set | 9.74e-08 | 190 | 103 | 10 | PF07679 | |
| Domain | - | CADM3 COL7A1 HLA-A HLA-C EMB HLA-DRA HLA-G MYOM3 MDGA2 IGSF22 NEO1 ROBO2 SIGLEC1 IGLL1 OSMR MUSK CD276 | 1.23e-07 | 663 | 103 | 17 | 2.60.40.10 |
| Domain | Ago_hook | 1.63e-07 | 3 | 103 | 3 | PF10427 | |
| Domain | TNRC6_PABC-bd | 1.63e-07 | 3 | 103 | 3 | IPR032226 | |
| Domain | Argonaute_hook_dom | 1.63e-07 | 3 | 103 | 3 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 1.63e-07 | 3 | 103 | 3 | PF16608 | |
| Domain | ArfGap | 4.94e-07 | 29 | 103 | 5 | SM00105 | |
| Domain | ArfGap | 4.94e-07 | 29 | 103 | 5 | PF01412 | |
| Domain | ARFGAP | 4.94e-07 | 29 | 103 | 5 | PS50115 | |
| Domain | ArfGAP | 4.94e-07 | 29 | 103 | 5 | IPR001164 | |
| Domain | C1-set | 5.06e-07 | 54 | 103 | 6 | PF07654 | |
| Domain | IGc2 | CADM3 MYOM3 MDGA2 IGSF22 NEO1 HMCN2 ROBO2 SIGLEC1 MUSK CD276 | 6.97e-07 | 235 | 103 | 10 | SM00408 |
| Domain | Ig_sub2 | CADM3 MYOM3 MDGA2 IGSF22 NEO1 HMCN2 ROBO2 SIGLEC1 MUSK CD276 | 6.97e-07 | 235 | 103 | 10 | IPR003598 |
| Domain | Ig/MHC_CS | 7.79e-07 | 58 | 103 | 6 | IPR003006 | |
| Domain | IG_MHC | 9.55e-07 | 60 | 103 | 6 | PS00290 | |
| Domain | MHC_I_a_C | 3.22e-06 | 6 | 103 | 3 | IPR010579 | |
| Domain | MHC_I_C | 3.22e-06 | 6 | 103 | 3 | PF06623 | |
| Domain | MHC_I | 4.86e-06 | 21 | 103 | 4 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 4.86e-06 | 21 | 103 | 4 | IPR001039 | |
| Domain | IG | CADM3 EMB MYOM3 MDGA2 IGSF22 NEO1 HMCN2 ROBO2 SIGLEC1 MUSK CD276 | 2.08e-05 | 421 | 103 | 11 | SM00409 |
| Domain | Ig_sub | CADM3 EMB MYOM3 MDGA2 IGSF22 NEO1 HMCN2 ROBO2 SIGLEC1 MUSK CD276 | 2.08e-05 | 421 | 103 | 11 | IPR003599 |
| Domain | M_domain | 3.01e-05 | 2 | 103 | 2 | PF12938 | |
| Domain | GW182_M_dom | 3.01e-05 | 2 | 103 | 2 | IPR026805 | |
| Domain | MHC_I/II-like_Ag-recog | 5.57e-05 | 38 | 103 | 4 | IPR011162 | |
| Domain | TIL_dom | 5.67e-05 | 14 | 103 | 3 | IPR002919 | |
| Domain | VWD | 8.66e-05 | 16 | 103 | 3 | SM00216 | |
| Domain | VWF_type-D | 8.66e-05 | 16 | 103 | 3 | IPR001846 | |
| Domain | VWFD | 8.66e-05 | 16 | 103 | 3 | PS51233 | |
| Domain | VWD | 8.66e-05 | 16 | 103 | 3 | PF00094 | |
| Domain | FN3 | 1.17e-04 | 199 | 103 | 7 | PS50853 | |
| Domain | FN3_dom | 1.59e-04 | 209 | 103 | 7 | IPR003961 | |
| Domain | fn3 | 2.77e-04 | 162 | 103 | 6 | PF00041 | |
| Domain | - | 3.03e-04 | 24 | 103 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 3.03e-04 | 24 | 103 | 3 | IPR011161 | |
| Domain | FN3 | 5.62e-04 | 185 | 103 | 6 | SM00060 | |
| Domain | Man6P_isomerase_rcpt-bd_dom | 8.25e-04 | 8 | 103 | 2 | IPR009011 | |
| Domain | C2-set_2 | 1.49e-03 | 41 | 103 | 3 | PF08205 | |
| Domain | CD80_C2-set | 1.49e-03 | 41 | 103 | 3 | IPR013162 | |
| Domain | TIL | 1.92e-03 | 12 | 103 | 2 | PF01826 | |
| Domain | Peptidase_M1 | 1.92e-03 | 12 | 103 | 2 | IPR001930 | |
| Domain | C8 | 1.92e-03 | 12 | 103 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 2.26e-03 | 13 | 103 | 2 | IPR014853 | |
| Domain | Peptidase_M1 | 2.26e-03 | 13 | 103 | 2 | PF01433 | |
| Domain | C8 | 2.26e-03 | 13 | 103 | 2 | SM00832 | |
| Domain | Peptidase_M1_N | 2.26e-03 | 13 | 103 | 2 | IPR014782 | |
| Domain | - | 2.52e-03 | 248 | 103 | 6 | 1.25.40.20 | |
| Domain | Ankyrin_rpt-contain_dom | 2.84e-03 | 254 | 103 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 2.84e-03 | 254 | 103 | 6 | PS50297 | |
| Domain | ig | 4.05e-03 | 190 | 103 | 5 | PF00047 | |
| Domain | Immunoglobulin | 4.05e-03 | 190 | 103 | 5 | IPR013151 | |
| Domain | CTCK_1 | 4.35e-03 | 18 | 103 | 2 | PS01185 | |
| Domain | VWC_out | 4.84e-03 | 19 | 103 | 2 | SM00215 | |
| Domain | UBA-like | 5.32e-03 | 64 | 103 | 3 | IPR009060 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 7.30e-08 | 9 | 71 | 4 | MM14527 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 1.38e-07 | 25 | 71 | 5 | MM15713 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 3.28e-07 | 133 | 71 | 8 | M16476 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 1.71e-06 | 18 | 71 | 4 | MM14525 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 2.33e-06 | 43 | 71 | 5 | M12617 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 2.42e-06 | 6 | 71 | 3 | M47468 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 2.69e-06 | 20 | 71 | 4 | MM1374 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 4.22e-06 | 7 | 71 | 3 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 4.22e-06 | 7 | 71 | 3 | M47530 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 4.22e-06 | 7 | 71 | 3 | M46421 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 6.90e-06 | 25 | 71 | 4 | MM1465 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 9.62e-06 | 98 | 71 | 6 | M965 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 1.01e-05 | 9 | 71 | 3 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 1.01e-05 | 9 | 71 | 3 | M46436 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 1.28e-05 | 29 | 71 | 4 | M1062 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 1.43e-05 | 10 | 71 | 3 | M48013 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 1.96e-05 | 11 | 71 | 3 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 2.61e-05 | 12 | 71 | 3 | M47529 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 2.64e-05 | 70 | 71 | 5 | M12294 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 3.38e-05 | 13 | 71 | 3 | M46434 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 3.44e-05 | 37 | 71 | 4 | M18615 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 5.20e-05 | 41 | 71 | 4 | M13519 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 5.93e-05 | 135 | 71 | 6 | MM14781 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 7.91e-05 | 17 | 71 | 3 | M27788 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 1.12e-04 | 19 | 71 | 3 | M48238 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 1.33e-04 | 52 | 71 | 4 | M13103 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 1.54e-04 | 54 | 71 | 4 | MM14871 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 2.04e-04 | 58 | 71 | 4 | M11980 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 3.66e-04 | 28 | 71 | 3 | M48253 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 3.70e-04 | 6 | 71 | 2 | MM15083 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 4.38e-04 | 360 | 71 | 8 | M27267 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 4.77e-04 | 129 | 71 | 5 | M39693 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 5.47e-04 | 32 | 71 | 3 | M48012 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 5.47e-04 | 32 | 71 | 3 | M27900 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 5.77e-04 | 76 | 71 | 4 | MM14526 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 6.36e-04 | 78 | 71 | 4 | M973 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 6.55e-04 | 34 | 71 | 3 | M46422 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 7.14e-04 | 35 | 71 | 3 | M27190 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 8.41e-04 | 37 | 71 | 3 | M29790 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | RAF1 HLA-A HLA-C ERAP1 HLA-DRA HLA-G HLA-H RASGRP1 LMO7 SIGLEC1 IGLL1 | 8.77e-04 | 719 | 71 | 11 | MM14540 |
| Pathway | WP_TCELL_ACTIVATION_SARSCOV2 | 1.00e-03 | 88 | 71 | 4 | M42580 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.00e-03 | 88 | 71 | 4 | M16004 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 1.04e-03 | 89 | 71 | 4 | M39398 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 1.09e-03 | 90 | 71 | 4 | M820 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 1.14e-03 | 41 | 71 | 3 | M29748 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 1.22e-03 | 42 | 71 | 3 | M39703 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 1.22e-03 | 42 | 71 | 3 | MM15822 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.60e-03 | 12 | 71 | 2 | MM15093 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.60e-03 | 12 | 71 | 2 | M27352 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.69e-03 | 47 | 71 | 3 | M29777 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 1.91e-03 | 49 | 71 | 3 | M48250 | |
| Pubmed | Mapping of 12 markers in the proximal region of mouse chromosome 17 using recombinant t haplotypes. | 3.60e-12 | 15 | 107 | 6 | 7749235 | |
| Pubmed | Organization and evolution of D region class I genes in the mouse major histocompatibility complex. | 1.39e-11 | 8 | 107 | 5 | 3701254 | |
| Pubmed | A region flanking H-2K is duplicated to a distant site in most mouse t haplotypes. | 1.39e-11 | 8 | 107 | 5 | 3013762 | |
| Pubmed | 1.39e-11 | 8 | 107 | 5 | 3410314 | ||
| Pubmed | 1.39e-11 | 8 | 107 | 5 | 37934601 | ||
| Pubmed | 1.39e-11 | 8 | 107 | 5 | 6316154 | ||
| Pubmed | 1.39e-11 | 8 | 107 | 5 | 20173027 | ||
| Pubmed | A novel Creb family gene telomeric of HLA-DRA in the HLA complex. | 3.13e-11 | 9 | 107 | 5 | 8586413 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 3.13e-11 | 9 | 107 | 5 | 12640130 | |
| Pubmed | 3.13e-11 | 9 | 107 | 5 | 17128277 | ||
| Pubmed | Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. | 3.13e-11 | 9 | 107 | 5 | 21300875 | |
| Pubmed | Autosomal phosphoglycerate kinase linked to mouse major histocompatibility complex. | 3.13e-11 | 9 | 107 | 5 | 628373 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 6.24e-11 | 10 | 107 | 5 | 20664521 | |
| Pubmed | 6.24e-11 | 10 | 107 | 5 | 6096010 | ||
| Pubmed | Gene organization and recombinational hotspots in the murine major histocompatibility complex. | 6.24e-11 | 10 | 107 | 5 | 3754180 | |
| Pubmed | ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides. | 6.24e-11 | 10 | 107 | 5 | 23863903 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | AGAP5 PCLO PPP1R13B TNRC6B AGAP11 TNRC6C TBK1 TNRC6A AGAP9 AGAP4 AGAP6 | 8.34e-11 | 218 | 107 | 11 | 33378226 |
| Pubmed | 1.14e-10 | 11 | 107 | 5 | 22522492 | ||
| Pubmed | 1.14e-10 | 11 | 107 | 5 | 1676981 | ||
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 1.14e-10 | 11 | 107 | 5 | 15381706 | |
| Pubmed | 1.14e-10 | 11 | 107 | 5 | 2911572 | ||
| Pubmed | 3.16e-10 | 13 | 107 | 5 | 27713690 | ||
| Pubmed | 3.16e-10 | 13 | 107 | 5 | 8835526 | ||
| Pubmed | Meiotic mapping of murine chromosome 17: the string of loci around l(17)-2Pas. | 3.16e-10 | 13 | 107 | 5 | 1794044 | |
| Pubmed | Extensive polymorphism surrounding the murine Ia A beta chain gene. | 3.16e-10 | 13 | 107 | 5 | 6311906 | |
| Pubmed | 4.91e-10 | 14 | 107 | 5 | 3860873 | ||
| Pubmed | 4.91e-10 | 14 | 107 | 5 | 3745925 | ||
| Pubmed | 4.91e-10 | 14 | 107 | 5 | 22453919 | ||
| Pubmed | No dosage effect of recombinational hotspots in the mouse major histocompatibility complex. | 4.91e-10 | 14 | 107 | 5 | 7910587 | |
| Pubmed | 1.07e-09 | 16 | 107 | 5 | 32723479 | ||
| Pubmed | 1.07e-09 | 16 | 107 | 5 | 1799792 | ||
| Pubmed | Localization of a mouse heat shock Hsp70 gene within the H-2 complex. | 1.51e-09 | 17 | 107 | 5 | 1978715 | |
| Pubmed | Tracts of high or low sequence divergence in the mouse major histocompatibility complex. | 2.08e-09 | 18 | 107 | 5 | 6098460 | |
| Pubmed | Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks. | 2.82e-09 | 19 | 107 | 5 | 2576007 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 1705528 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 2808323 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 21088134 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 69663 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 2.94e-09 | 7 | 107 | 4 | 12459592 | |
| Pubmed | Multiple sequences related to classical histocompatibility antigens in the mouse genome. | 2.94e-09 | 7 | 107 | 4 | 6264319 | |
| Pubmed | Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci. | 2.94e-09 | 7 | 107 | 4 | 2714856 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 10500200 | ||
| Pubmed | Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences. | 2.94e-09 | 7 | 107 | 4 | 2391419 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 15671142 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 14215561 | ||
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 2.94e-09 | 7 | 107 | 4 | 28234229 | |
| Pubmed | Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse. | 2.94e-09 | 7 | 107 | 4 | 6242891 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 17512611 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 7018573 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 2642506 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 9037062 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 1840571 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 20957233 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 11580250 | ||
| Pubmed | V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules. | 2.94e-09 | 7 | 107 | 4 | 11086076 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 12750360 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 18416856 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 2.94e-09 | 7 | 107 | 4 | 20974936 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 10704462 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 22573867 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 2.94e-09 | 7 | 107 | 4 | 2908875 | |
| Pubmed | Comparison of exon 5 sequences from 35 class I genes of the BALB/c mouse. | 2.94e-09 | 7 | 107 | 4 | 2584927 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 3496275 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 12147629 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 3458188 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 19462379 | ||
| Pubmed | Structural diversity of the classical H-2 genes: K, D, and L. | 2.94e-09 | 7 | 107 | 4 | 1730883 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 3680952 | ||
| Pubmed | Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease. | 2.94e-09 | 7 | 107 | 4 | 19004778 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 2.94e-09 | 7 | 107 | 4 | 6300850 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 2.94e-09 | 7 | 107 | 4 | 6265910 | |
| Pubmed | Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. | 2.94e-09 | 7 | 107 | 4 | 18453559 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 2.94e-09 | 7 | 107 | 4 | 2906539 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 3013627 | ||
| Pubmed | DNA sequence of the mouse H-2Dd transplantation antigen gene. | 2.94e-09 | 7 | 107 | 4 | 3856254 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 3894562 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 27385590 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 2.94e-09 | 7 | 107 | 4 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 2.94e-09 | 7 | 107 | 4 | 18383043 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 16272298 | ||
| Pubmed | Tissue-specific expression of an unusual H-2 (class I)-related gene. | 2.94e-09 | 7 | 107 | 4 | 6956903 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 8833240 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 21178009 | ||
| Pubmed | Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. | 2.94e-09 | 7 | 107 | 4 | 6604582 | |
| Pubmed | Isolation of a cDNA clone for the murine transplantation antigen H-2Kb. | 2.94e-09 | 7 | 107 | 4 | 6954478 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 34525366 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 3374494 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 2.94e-09 | 7 | 107 | 4 | 3025084 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 2543831 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 2.94e-09 | 7 | 107 | 4 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 2.94e-09 | 7 | 107 | 4 | 6786753 | |
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 6583704 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 6571712 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 9222352 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 12006653 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 1699529 | ||
| Interaction | KCNA3 interactions | HSPD1 RAF1 EPPK1 ABL2 HLA-A COL27A1 BAX TNRC6B EPB41L3 PHGDH DHX15 EEF1G RACK1 CAPRIN2 LRP2 TNKS1BP1 | 9.70e-06 | 871 | 104 | 16 | int:KCNA3 |
| Interaction | TNRC6B interactions | 1.56e-05 | 282 | 104 | 9 | int:TNRC6B | |
| Interaction | LILRB1 interactions | 1.56e-05 | 10 | 104 | 3 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 1.56e-05 | 10 | 104 | 3 | int:LILRB2 | |
| Interaction | MEX3B interactions | 1.99e-05 | 222 | 104 | 8 | int:MEX3B | |
| Interaction | GARRE1 interactions | 2.56e-05 | 167 | 104 | 7 | int:GARRE1 | |
| Interaction | AGO4 interactions | 3.37e-05 | 118 | 104 | 6 | int:AGO4 | |
| Interaction | ZFP36 interactions | 4.28e-05 | 181 | 104 | 7 | int:ZFP36 | |
| Interaction | PXN interactions | 5.85e-05 | 334 | 104 | 9 | int:PXN | |
| Interaction | TNRC6C interactions | 8.09e-05 | 138 | 104 | 6 | int:TNRC6C | |
| Interaction | HLA-H interactions | 8.61e-05 | 17 | 104 | 3 | int:HLA-H | |
| Interaction | HLA-C interactions | 8.93e-05 | 353 | 104 | 9 | int:HLA-C | |
| Interaction | PTPRO interactions | 9.85e-05 | 143 | 104 | 6 | int:PTPRO | |
| Interaction | TNRC6A interactions | 1.02e-04 | 280 | 104 | 8 | int:TNRC6A | |
| Interaction | CPEB1 interactions | 1.10e-04 | 146 | 104 | 6 | int:CPEB1 | |
| Cytoband | 6p21.3 | 2.14e-06 | 250 | 107 | 7 | 6p21.3 | |
| Cytoband | 2p16.2 | 1.92e-04 | 9 | 107 | 2 | 2p16.2 | |
| Cytoband | 2q21.3 | 5.54e-04 | 15 | 107 | 2 | 2q21.3 | |
| Cytoband | 1p12 | 1.56e-03 | 25 | 107 | 2 | 1p12 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 7.30e-09 | 17 | 77 | 5 | 1291 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.70e-08 | 161 | 77 | 9 | 593 | |
| GeneFamily | ArfGAPs | 2.66e-07 | 33 | 77 | 5 | 395 | |
| GeneFamily | C1-set domain containing | 9.24e-07 | 42 | 77 | 5 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 1.17e-06 | 44 | 77 | 5 | 588 | |
| GeneFamily | Immunoglobulin like domain containing | 1.81e-05 | 193 | 77 | 7 | 594 | |
| GeneFamily | Fibronectin type III domain containing | 6.17e-05 | 160 | 77 | 6 | 555 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.60e-04 | 25 | 77 | 3 | 775 | |
| GeneFamily | Ankyrin repeat domain containing | 5.80e-04 | 242 | 77 | 6 | 403 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 6.55e-04 | 40 | 77 | 3 | 592 | |
| GeneFamily | CD molecules|Mucins | 3.57e-03 | 21 | 77 | 2 | 648 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 4.65e-03 | 24 | 77 | 2 | 654 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 4.12e-08 | 24 | 107 | 5 | MM3773 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 4.05e-07 | 37 | 107 | 5 | MM1121 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 4.60e-07 | 16 | 107 | 4 | MM3766 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 6.88e-07 | 41 | 107 | 5 | MM710 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 9.70e-07 | 19 | 107 | 4 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 9.70e-07 | 19 | 107 | 4 | MM862 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 9.87e-07 | 44 | 107 | 5 | MM485 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 1.20e-06 | 132 | 107 | 7 | MM841 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 1.21e-06 | 20 | 107 | 4 | MM3682 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 1.49e-06 | 21 | 107 | 4 | MM651 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 2.37e-06 | 209 | 107 | 8 | MM1058 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_NK_CELL_AGEING | 2.76e-06 | 96 | 107 | 6 | MM3834 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 3.11e-06 | 25 | 107 | 4 | MM672 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 3.34e-06 | 56 | 107 | 5 | MM3852 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 4.17e-06 | 103 | 107 | 6 | MM476 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 7.59e-06 | 31 | 107 | 4 | MM3729 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 1.24e-05 | 73 | 107 | 5 | M11428 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 1.25e-05 | 35 | 107 | 4 | MM674 | |
| Coexpression | DURAND_STROMA_NS_UP | 1.52e-05 | 194 | 107 | 7 | MM962 | |
| Coexpression | PEREZ_TP63_TARGETS | TSHZ3 EPPK1 COL27A1 PPP1R13B TNRC6C EPB41L3 RASGRP1 RASEF IL17RB | 1.58e-05 | 356 | 107 | 9 | M10761 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.93e-05 | 39 | 107 | 4 | MM3758 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 1.93e-05 | 39 | 107 | 4 | MM3725 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE | 2.14e-05 | 40 | 107 | 4 | M41037 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING | 2.19e-05 | 82 | 107 | 5 | MM3858 | |
| Coexpression | PEREZ_TP53_AND_TP63_TARGETS | 2.32e-05 | 207 | 107 | 7 | M14566 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 2.87e-05 | 43 | 107 | 4 | MM1204 | |
| Coexpression | LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_POSITIVE | 2.87e-05 | 43 | 107 | 4 | M41036 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 3.07e-05 | 146 | 107 | 6 | MM856 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 3.09e-05 | 88 | 107 | 5 | MM1087 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 3.14e-05 | 44 | 107 | 4 | MM3775 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 3.44e-05 | 90 | 107 | 5 | MM3756 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 3.52e-05 | 221 | 107 | 7 | M39222 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_PODOCYTE_AGEING | 3.62e-05 | 222 | 107 | 7 | MM3733 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING | 3.63e-05 | 91 | 107 | 5 | MM3720 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 3.75e-05 | 46 | 107 | 4 | MM3712 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 4.83e-05 | 49 | 107 | 4 | MM1287 | |
| Coexpression | ZHENG_CORD_BLOOD_C8_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_2 | 4.93e-05 | 97 | 107 | 5 | M39217 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 5.18e-05 | 98 | 107 | 5 | MM460 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 5.23e-05 | 50 | 107 | 4 | MM3805 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 5.71e-05 | 100 | 107 | 5 | MM458 | |
| Coexpression | HOLLERN_MICROACINAR_BREAST_TUMOR_UP | 6.11e-05 | 52 | 107 | 4 | MM968 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 6.11e-05 | 52 | 107 | 4 | MM3808 | |
| Coexpression | TRAVAGLINI_LUNG_MESOTHELIAL_CELL | HSPD1 CADM3 EMB HLA-DRA BAX PHGDH EEF1G TMEM132A KLK8 LRP2 PAPPA | 7.11e-05 | 649 | 107 | 11 | M41679 |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 8.78e-05 | 57 | 107 | 4 | MM3716 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_DN | 9.24e-05 | 178 | 107 | 6 | M2980 | |
| Coexpression | HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR | 9.40e-05 | 58 | 107 | 4 | MM661 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 1.01e-04 | 59 | 107 | 4 | MM3688 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 1.01e-04 | 59 | 107 | 4 | MM3704 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 1.56e-04 | 196 | 107 | 6 | MM3746 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_PROXIMAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 1.56e-04 | 196 | 107 | 6 | MM3730 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_DISTAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 1.58e-04 | 124 | 107 | 5 | MM3726 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SLC37A1 CADM3 PCLO MUC19 MDGA2 TNRC6C CAPRIN2 TNRC6A ROBO2 PAPPA SMIM17 SPAG17 WNK3 PDE11A | 1.64e-04 | 1106 | 107 | 14 | M39071 |
| Coexpression | GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN | 1.75e-04 | 200 | 107 | 6 | M7080 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN | 1.75e-04 | 200 | 107 | 6 | M9588 | |
| Coexpression | MA_RAT_AGING_UP | 1.77e-04 | 127 | 107 | 5 | MM16096 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_FIBROBLAST_AGEING | 1.77e-04 | 127 | 107 | 5 | MM3856 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 1.89e-04 | 203 | 107 | 6 | MM3795 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 2.33e-04 | 211 | 107 | 6 | MM17081 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING | 2.42e-04 | 74 | 107 | 4 | MM3796 | |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 2.51e-04 | 137 | 107 | 5 | MM16612 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING | 2.55e-04 | 75 | 107 | 4 | MM3759 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 2.55e-04 | 75 | 107 | 4 | MM3718 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_PROFESSIONAL_ANTIGEN_PRESENTING_CELL_AGEING | 3.07e-04 | 143 | 107 | 5 | MM3673 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 | 3.13e-04 | 223 | 107 | 6 | MM838 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 3.59e-04 | 82 | 107 | 4 | MM3777 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 3.94e-04 | 84 | 107 | 4 | MM1049 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_AORTIC_ENDOTHELIAL_CELL_AGEING | 4.11e-04 | 329 | 107 | 7 | MM3671 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9 | 4.12e-04 | 85 | 107 | 4 | MM1279 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | 4.31e-04 | 86 | 107 | 4 | MM834 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_LOOP_OF_HENLE_THICK_ASCENDING_LIMB_EPITHELIAL_CELL_AGEING | 4.43e-04 | 238 | 107 | 6 | MM3728 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 4.50e-04 | 87 | 107 | 4 | MM652 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_BRONCHIAL_SMOOTH_MUSCLE_CELL_AGEING | 4.57e-04 | 156 | 107 | 5 | MM3763 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_BASAL_CELL_OF_EPIDERMIS_AGEING | 4.84e-04 | 158 | 107 | 5 | MM3851 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | HSPD1 PRUNE2 TSHZ3 PCLO EPB41L3 ARHGAP5 RASGRP1 NEO1 NAV2 ROBO2 UNC80 IL17RB | 4.86e-04 | 946 | 107 | 12 | M39169 |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 5.12e-04 | 90 | 107 | 4 | MM750 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 5.57e-04 | 92 | 107 | 4 | MM3748 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 5.80e-04 | 93 | 107 | 4 | MM1185 | |
| Coexpression | GSE14415_INDUCED_TREG_VS_TCONV_DN | 5.90e-04 | 165 | 107 | 5 | M2960 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 6.06e-04 | 166 | 107 | 5 | M6826 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 6.13e-04 | 703 | 107 | 10 | MM1055 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL | 6.30e-04 | 41 | 107 | 3 | M39158 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 6.79e-04 | 97 | 107 | 4 | MM3789 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.48e-08 | 92 | 107 | 6 | d2c1d25e5bb6ba4f406e916e3c0a5ad05492e59d | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.48e-08 | 92 | 107 | 6 | 926e02725a03d8473eda25d4aef63e34a6566224 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.62e-07 | 179 | 107 | 7 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-07 | 183 | 107 | 7 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 3.52e-07 | 187 | 107 | 7 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-07 | 188 | 107 | 7 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-07 | 188 | 107 | 7 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-07 | 191 | 107 | 7 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.35e-07 | 193 | 107 | 7 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.00e-07 | 197 | 107 | 7 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.88e-06 | 180 | 107 | 6 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.03e-06 | 181 | 107 | 6 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 184 | 107 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 184 | 107 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 184 | 107 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.71e-06 | 185 | 107 | 6 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.89e-06 | 186 | 107 | 6 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 5.89e-06 | 186 | 107 | 6 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.07e-06 | 187 | 107 | 6 | 698ae9eefa8ba97fea8ea61e4e868edd194de03b | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 6.07e-06 | 187 | 107 | 6 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Endo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.07e-06 | 187 | 107 | 6 | ed8816433d1086a634892502898255b487a2d4a7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-06 | 187 | 107 | 6 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.07e-06 | 187 | 107 | 6 | d8b09398400a178b03e641af1476c4dac0c6e82a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-06 | 189 | 107 | 6 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-06 | 189 | 107 | 6 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.45e-06 | 189 | 107 | 6 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 6.45e-06 | 189 | 107 | 6 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 192 | 107 | 6 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.06e-06 | 192 | 107 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 7.06e-06 | 192 | 107 | 6 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 7.06e-06 | 192 | 107 | 6 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 192 | 107 | 6 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.27e-06 | 193 | 107 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.49e-06 | 194 | 107 | 6 | 3701ca87c6dc9ccd7b4146e56371546174d26c36 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.49e-06 | 194 | 107 | 6 | 65f9bf126be26114c2c3f4c46d48318986212a92 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.49e-06 | 194 | 107 | 6 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 197 | 107 | 6 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 197 | 107 | 6 | 01e9505d947e5a5f005d1eab96301f84fc194809 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-gd_T|URO / Disease, condition lineage and cell class | 8.41e-06 | 198 | 107 | 6 | cb584f7754ef4e6d9ec7155022852f2d2676ab4f | |
| ToppCell | BLOOD--(3)_MNP-(3)_Intermediate_monocytes|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.41e-06 | 198 | 107 | 6 | 70c3efd4f6026a6a6065be632160a265d9ecd1e4 | |
| ToppCell | medial-Endothelial-Capillary|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.91e-06 | 200 | 107 | 6 | fd4dcdc67db2a5dbdd54bd2ae975c66df904d4d8 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.91e-06 | 200 | 107 | 6 | 2ae62c428728c1d9d4471d4be24bd6ab074fa22c | |
| ToppCell | distal-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.91e-06 | 200 | 107 | 6 | 8daf09d63c2fda6da6e5b66f96e7449ee8b17029 | |
| ToppCell | medial-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.91e-06 | 200 | 107 | 6 | e4f390dfd4dd25600f0f7a17c5523283a5966e92 | |
| ToppCell | medial-Endothelial-Capillary-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.91e-06 | 200 | 107 | 6 | 4291b5453e98e20ec8150a96ccc865a5964bc645 | |
| ToppCell | distal-Endothelial-Capillary-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.91e-06 | 200 | 107 | 6 | ab96d3d801373459a2503ccfb665dc3f43bfb5a1 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.56e-05 | 130 | 107 | 5 | 6c6a8b77af08b30b424d4f5def37315d3c6e28b2 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_fibroblast-mesenchymal_B|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.56e-05 | 130 | 107 | 5 | 0706092f6b466585b3b4808b3b982a122d66cfcf | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.50e-05 | 162 | 107 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 164 | 107 | 5 | 1d0d88132baaa3154c3e6e4ef0aff795afab08a2 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 164 | 107 | 5 | bd2e10b015d5e6a338675500ec5d81dc39583b3e | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.20e-05 | 167 | 107 | 5 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 5.65e-05 | 170 | 107 | 5 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.14e-05 | 173 | 107 | 5 | 0a355386210a13927ea29b10b64cb059459952d4 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.14e-05 | 173 | 107 | 5 | 3678b300cad4effd7f49bfb043305ed512693848 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.31e-05 | 174 | 107 | 5 | 4a1b67ce5ea353b3f81f59fa57da07668146afca | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 6.66e-05 | 176 | 107 | 5 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.03e-05 | 178 | 107 | 5 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.03e-05 | 178 | 107 | 5 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.03e-05 | 178 | 107 | 5 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.03e-05 | 178 | 107 | 5 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.03e-05 | 178 | 107 | 5 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.22e-05 | 179 | 107 | 5 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-05 | 180 | 107 | 5 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.41e-05 | 180 | 107 | 5 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 181 | 107 | 5 | 35eefd874a892eaf21f24fdce89e7ea3b8ee285f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-05 | 181 | 107 | 5 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 181 | 107 | 5 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 181 | 107 | 5 | e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-05 | 181 | 107 | 5 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 7.61e-05 | 181 | 107 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 182 | 107 | 5 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 182 | 107 | 5 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 182 | 107 | 5 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.81e-05 | 182 | 107 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 182 | 107 | 5 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 182 | 107 | 5 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.01e-05 | 183 | 107 | 5 | 6cdadb3ece45a94a2915063aa461048e1d371ccd | |
| ToppCell | moderate-Epithelial-IRC-IFNG_responsive_cell|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.01e-05 | 183 | 107 | 5 | 4ba879552e2101a341f3224826d364ac64c72260 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.01e-05 | 183 | 107 | 5 | 8714d3e7663c93cdf9b25b647353572e136f30c3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.01e-05 | 183 | 107 | 5 | c7fc96ac1d5d31ccefe0c1fc6ec76c7d8607a172 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 8.22e-05 | 184 | 107 | 5 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.22e-05 | 184 | 107 | 5 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.22e-05 | 184 | 107 | 5 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.22e-05 | 184 | 107 | 5 | 73eaac74a88bf5fd23d88035fac398ac43b268c5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Endo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.22e-05 | 184 | 107 | 5 | 65f651d4b93ed0b52f526d3f517d92b6c62aaec3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.22e-05 | 184 | 107 | 5 | 9001d35cdde061d06f8545b3cee942d1299129db | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-05 | 184 | 107 | 5 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.43e-05 | 185 | 107 | 5 | 03df43e9c2ce4ec24ffed8e4e2993f94ba951c8b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.43e-05 | 185 | 107 | 5 | dbdbd6593cd98550238519746bb45fbf0617550b | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 8.43e-05 | 185 | 107 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.43e-05 | 185 | 107 | 5 | de2c24719946d5a37a982d816776cea7f3984c49 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-05 | 186 | 107 | 5 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.65e-05 | 186 | 107 | 5 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-05 | 186 | 107 | 5 | 422d24e3e1a9397bb7d5c7ef75de2fd7ae8e136d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-05 | 186 | 107 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-05 | 186 | 107 | 5 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-05 | 186 | 107 | 5 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.65e-05 | 186 | 107 | 5 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-05 | 186 | 107 | 5 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| Computational | Genes in the cancer module 293. | 2.16e-07 | 12 | 51 | 4 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 4.34e-07 | 14 | 51 | 4 | MODULE_143 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.23e-10 | 10 | 104 | 5 | DOID:1969 (implicated_via_orthology) | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.47e-06 | 7 | 104 | 3 | DOID:0081267 (implicated_via_orthology) | |
| Disease | Bicuspid aortic valve | 3.68e-05 | 3 | 104 | 2 | HP_0001647 | |
| Disease | carotid artery disease (is_marker_for) | 3.96e-05 | 19 | 104 | 3 | DOID:3407 (is_marker_for) | |
| Disease | serum IgE measurement | 7.86e-05 | 64 | 104 | 4 | EFO_0004579 | |
| Disease | 7-alpha-hydroxy-3-oxo-4-cholestenoate 7-Hoca measurement | 1.22e-04 | 5 | 104 | 2 | EFO_0021116 | |
| Disease | autism spectrum disorder, schizophrenia | 1.63e-04 | 327 | 104 | 7 | EFO_0003756, MONDO_0005090 | |
| Disease | eicosapentaenoic acid measurement | 1.78e-04 | 31 | 104 | 3 | EFO_0007760 | |
| Disease | dietary heme iron intake measurement, type 2 diabetes mellitus | 1.83e-04 | 6 | 104 | 2 | EFO_0008355, MONDO_0005148 | |
| Disease | grapefruit juice consumption measurement | 2.55e-04 | 7 | 104 | 2 | EFO_0010094 | |
| Disease | cholelithiasis | 2.71e-04 | 88 | 104 | 4 | EFO_0004799 | |
| Disease | platelet-to-lymphocyte ratio | 3.08e-04 | 363 | 104 | 7 | EFO_0008446 | |
| Disease | lung adenocarcinoma | 3.86e-04 | 174 | 104 | 5 | EFO_0000571 | |
| Disease | familial hyperlipidemia | 5.49e-04 | 106 | 104 | 4 | MONDO_0001336 | |
| Disease | gallstones | 5.89e-04 | 108 | 104 | 4 | EFO_0004210 | |
| Disease | beta-2 microglobulin measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0005197 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 7.94e-04 | 12 | 104 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | complement C4 measurement | 8.29e-04 | 52 | 104 | 3 | EFO_0004984 | |
| Disease | hematocrit | HIVEP1 HLA-A PPP1R13B TNRC6B PHGDH TBK1 LRP2 OSMR MTX1 MUSK MAP3K19 | 8.85e-04 | 1011 | 104 | 11 | EFO_0004348 |
| Disease | von Willebrand factor measurement | 1.03e-03 | 56 | 104 | 3 | EFO_0004629 | |
| Disease | natural cytotoxicity triggering receptor 3 measurement | 1.09e-03 | 14 | 104 | 2 | EFO_0008243 | |
| Disease | Proteinuria | 1.25e-03 | 15 | 104 | 2 | HP_0000093 | |
| Disease | response to thioamide, Drug-induced agranulocytosis | 1.43e-03 | 16 | 104 | 2 | EFO_0007633, HP_0012235 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.60e-03 | 239 | 104 | 5 | EFO_0010934 | |
| Disease | respiratory symptom change measurement, response to placebo | 1.62e-03 | 17 | 104 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | upper aerodigestive tract neoplasm | 1.82e-03 | 246 | 104 | 5 | EFO_0004284 | |
| Disease | Takayasu arteritis | 1.89e-03 | 148 | 104 | 4 | EFO_1001857 | |
| Disease | lymphocyte count | HIVEP1 EPPK1 CARMIL2 HLA-A HLA-C HLA-DRA HLA-G BAX TNRC6B ERLEC1 ROBO2 PAPPA SIGLEC1 | 1.92e-03 | 1464 | 104 | 13 | EFO_0004587 |
| Disease | Malignant Glioma | 1.96e-03 | 70 | 104 | 3 | C0555198 | |
| Disease | mixed gliomas | 1.96e-03 | 70 | 104 | 3 | C0259783 | |
| Disease | bipolar disorder (is_marker_for) | 2.02e-03 | 19 | 104 | 2 | DOID:3312 (is_marker_for) | |
| Disease | eosinophil count | HIVEP1 CARMIL2 HLA-A HLA-C EMB HLA-DRA HLA-G CDC20B BAX RASGRP1 TIGD2 TNKS1BP1 MUSK | 2.21e-03 | 1488 | 104 | 13 | EFO_0004842 |
| Disease | Non-Small Cell Lung Carcinoma | 2.29e-03 | 156 | 104 | 4 | C0007131 | |
| Disease | systemising measurement | 2.47e-03 | 21 | 104 | 2 | EFO_0010221 | |
| Disease | disease | 2.47e-03 | 21 | 104 | 2 | EFO_0000408 | |
| Disease | circadian rhythm | 2.69e-03 | 163 | 104 | 4 | EFO_0004354 | |
| Disease | cervical squamous cell carcinoma (is_marker_for) | 2.71e-03 | 22 | 104 | 2 | DOID:3744 (is_marker_for) | |
| Disease | C-peptide measurement | 2.71e-03 | 22 | 104 | 2 | EFO_0005187 | |
| Disease | serum IgM measurement | 2.71e-03 | 22 | 104 | 2 | EFO_0004993 | |
| Disease | Down syndrome (is_marker_for) | 2.71e-03 | 22 | 104 | 2 | DOID:14250 (is_marker_for) | |
| Disease | Ovarian Serous Adenocarcinoma | 2.97e-03 | 23 | 104 | 2 | C1335177 | |
| Disease | insulin sensitivity measurement | 2.97e-03 | 23 | 104 | 2 | EFO_0004471 | |
| Disease | Hodgkins lymphoma | 3.08e-03 | 82 | 104 | 3 | EFO_0000183 | |
| Disease | apolipoprotein A 1 measurement | COL7A1 HLA-G ZRANB3 DHX15 GPIHBP1 SLC12A3 TNKS1BP1 MUSK MINDY1 | 3.10e-03 | 848 | 104 | 9 | EFO_0004614 |
| Disease | breast carcinoma | EMB HLA-H TNRC6B EPB41L3 PHGDH ARHGAP5 SLC12A3 AOPEP TBXT SPAG17 | 3.22e-03 | 1019 | 104 | 10 | EFO_0000305 |
| Disease | antiphospholipid syndrome | 3.23e-03 | 24 | 104 | 2 | EFO_0002689 | |
| Disease | thalamus volume | 3.41e-03 | 85 | 104 | 3 | EFO_0006935 | |
| Disease | Hypertrophic obstructive cardiomyopathy | 3.50e-03 | 25 | 104 | 2 | C4551472 | |
| Disease | susceptibility to Mycobacterium tuberculosis infection measurement | 3.52e-03 | 86 | 104 | 3 | EFO_0008407 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVGWVKNTSKGTVTG | 36 | P14621 | |
| WEGSSQGQTKPSEKS | 521 | Q96P64 | |
| SGKTSVVVGTWNQEE | 371 | Q96DZ1 | |
| SIWEGSSQGQTKPSI | 406 | Q8TF27 | |
| NSIWEGSSQGQTKPS | 586 | Q5VTM2 | |
| SEVRSKNGQGWVPSN | 146 | P42684 | |
| SGNKAGQVWAPEGST | 46 | Q9H6U8 | |
| SQGPESATWKTLGQQ | 1281 | Q6F5E8 | |
| KATQTESQPWIGSEG | 671 | O95267 | |
| KPEGRSVTWTSDQSG | 251 | Q8N6M6 | |
| WQDGQGVPLTGNVTT | 396 | Q5ZPR3 | |
| QSWGSPKVTKDGVTV | 66 | P10809 | |
| SQPWTSDETVVAGGT | 31 | Q8N126 | |
| ETGSGKTTQIPQWCV | 161 | O43143 | |
| SSSSVKPVQVAGADW | 396 | Q96KQ4 | |
| WEGSSQGQTKPSEKS | 521 | Q5VW22 | |
| WSGSQQVEQPTGSVL | 496 | P04049 | |
| PQTWKDVIGGSQHSS | 411 | Q9H4I0 | |
| DFQWKNVGPNTTSTV | 571 | Q99650 | |
| LKGHNGWVTQIATTP | 11 | P63244 | |
| SVLDWKPQGSVSEGS | 496 | Q8IZ41 | |
| GDGTFQKWAAVVVPS | 261 | P01893 | |
| GKVTITGTSQNWTPD | 76 | P47874 | |
| GDGTFQKWAAVVVPS | 261 | P17693 | |
| PKTTGAGAQTQWTQE | 556 | Q99102 | |
| ANGSWQEAVTPSSVT | 401 | P40425 | |
| GKSVWGSLAVQNSPK | 341 | P18615 | |
| WQSSRVQDPTGKGAG | 141 | Q8IV16 | |
| PTITWQKEGLNVATG | 3971 | Q8NDA2 | |
| GVNSRTNTPVETWKG | 516 | Q6UXG2 | |
| EAFQTQTRPSGGKWT | 106 | Q9NRM6 | |
| FWGTTKVEITASQPT | 76 | Q9NZ08 | |
| GDGTFQKWAAVVVPS | 261 | P10321 | |
| PVGVTNGWTDSTVSQ | 2876 | Q9Y6V0 | |
| GTNGQSAEVTWITGP | 4451 | Q7Z5P9 | |
| STENSNEVQVPWGKG | 271 | Q9HCR9 | |
| KLQVWSGTEVTAPQG | 341 | P25021 | |
| WKGEQTPIITQSTNG | 121 | Q8N5J2 | |
| NVENWPTVQGTSKSS | 366 | Q8WWI1 | |
| NPTSPAADGTQVTKW | 4566 | P98164 | |
| TGPSVTVTCTEGKWN | 1261 | Q13219 | |
| TTIENPLWSSSGNKG | 861 | Q7Z553 | |
| IKNSQVWVGTIGSGP | 641 | Q9BX63 | |
| AQSSGTGKPLESWIN | 481 | Q8IZD4 | |
| TQVINGLVQTTGWPS | 161 | P57057 | |
| TVTWKADGTPITQGV | 146 | P15814 | |
| AVTITWNAPTQDGGA | 716 | Q8N9C0 | |
| GTPTWQTVTIFVAGV | 166 | Q07812 | |
| AWKADGSPVNTGVET | 41 | P0CF74 | |
| TVWQEGTGQTPAKQA | 1771 | Q8IZC6 | |
| WLRNGKPVTTGVSET | 146 | P01903 | |
| SQSQISPKSWGVATA | 561 | Q6IMN6 | |
| GDGTFQKWAAVVVPS | 261 | P04439 | |
| ATGQGTPKNDVTVWT | 461 | Q86Y33 | |
| TQPGQKCTVSGWGTV | 146 | O60259 | |
| ATKTWEQVKSTGGPS | 161 | Q8TBB5 | |
| QWTAASGPVTGYKVQ | 251 | Q02388 | |
| PVSSNSKTAAWVTEG | 156 | P22680 | |
| GSTPEAAAQVVQWVS | 86 | P26641 | |
| TWYSSNGSVKVPVGV | 191 | Q6PCB8 | |
| WGAKASTPEVQSEQS | 251 | Q9HBV2 | |
| FIGGVTSTSQSWVQK | 811 | Q9Y2J2 | |
| GISEPDWQIKSSGNE | 761 | Q56UN5 | |
| KVQVEGGSGNFTWTS | 486 | Q5VU65 | |
| SQSPEVKGGTWSQAE | 931 | A6NGG8 | |
| SSTGHVQFGKSPQTW | 21 | Q13505 | |
| PSRSTSNGVNGEWGK | 331 | Q9HCJ0 | |
| ETGTTGDVAWQISPK | 1791 | Q8WUY3 | |
| SPGWGQTQAVETNIV | 306 | Q9P0V3 | |
| STGGGVAVTRPVTWQ | 356 | Q24JP5 | |
| TPGSGALQGQSVSVW | 2441 | P58107 | |
| TVTWETPVSGNGEIQ | 556 | Q92859 | |
| TSGKKNPVISQTGSW | 1046 | Q8IVL1 | |
| SQGFVEWSKAPQQTT | 81 | P0DL12 | |
| TWKGGIDNPAITSDQ | 1206 | Q13017 | |
| NWVKGPIAVGISFTT | 291 | Q86VD7 | |
| EKGGTVNTSSKIWEP | 6 | Q6Q759 | |
| NSIWEGSSQGQTKPS | 541 | A6NIR3 | |
| WFNQQKTDGIPVSGT | 86 | Q4W5G0 | |
| IKQWQISSGQGTPST | 566 | O15164 | |
| SAVKVKISSNWGNPG | 336 | Q8TC36 | |
| SNTGTGTVWEQDSEP | 2941 | Q8N2C7 | |
| VVTGSPRGDSQSSWK | 2501 | P04275 | |
| PRGDSQSSWKSVGSQ | 2506 | P04275 | |
| NWETEITAQPDGGKT | 156 | P05452 | |
| PGKTTAGSVDWTDQL | 1151 | Q9C0C2 | |
| TTVVANPGQWIVTNS | 296 | Q9GZP7 | |
| KKPEVNWGSSVQAGS | 606 | P55017 | |
| TDVTKNSVTLSWQPG | 531 | Q9HCK4 | |
| VDQTGPKAWKGSTTN | 151 | O43159 | |
| WSVSNGAVTPGSQAA | 351 | O15178 | |
| WGVSSPQDVQGVKGS | 21 | Q9BZZ2 | |
| TSAINKAQNGTPSWG | 531 | Q63HK5 | |
| QAWVGAQSPKSGEEA | 106 | P10073 | |
| TWEKVPVGTNGGVTV | 206 | Q96HH6 | |
| SPDSTIWKGQNGRTF | 416 | Q13470 | |
| TVKQEPANQTWGQGS | 26 | Q9P0L1 | |
| WAGSPKGTIQVITQG | 346 | O43175 | |
| GKESPEQQGRSTAWG | 1736 | A6NGW2 | |
| GSSVVTWKISDVAGP | 36 | Q6ZVU0 | |
| AGSSGIWEQTPQIRK | 1016 | P15822 | |
| TNEQSSVWAKTGGTV | 656 | Q8NDV7 | |
| ATTVDNGTSAWGKPI | 1071 | Q8NDV7 | |
| ISGVQKAENGPIDWS | 246 | Q9UHD2 | |
| VSQGEWKQPTGSDEL | 506 | Q9UPQ9 | |
| DGLTSQPGNEQWKSS | 711 | Q5FWF4 | |
| SGSENVPEGIKWNSS | 641 | Q9C0D4 | |
| PVQWVGISGTTQQSV | 1751 | Q9BYP7 | |
| PTITWIENGNAVSSG | 241 | O15146 | |
| GTSEWQTVNNKPIQG | 641 | Q5VTT5 |